Announcements

Twist Bioscience Corporation filed a Form 8-K on August 19, 2026, disclosing the filing of a prospectus supplement to register the resale of shares issuable to Invenra Inc. under agreements dated February 11, 2026.

Ultragenyx Pharmaceutical Inc. filed an 8-K with the U.S. Securities and Exchange Commission on August 19, 2026, announcing that the FDA granted accelerated approval for GENGLYCOS (pariglasgene brecaparvovec-opnr) in adult and pediatric patients eight years and older with glycogen storage disease type Ia.

Encore Capital Group, Inc. filed a Form 8-K with the SEC on August 19, 2026, disclosing the appointment of Robert Beck as a new independent director and the expansion of the Board of Directors from 8 to 9 members.

BKV Corporation filed a Form 10-K/A (Amendment No. 1) on August 19, 2026, amending its Annual Report on Form 10-K for the fiscal year ended December 31, 2025, originally filed with the SEC on March 6, 2026, to correct auditor consent language, recast financial …

Kimball Electronics, Inc. filed its Form 10-K annual report with the U.S. Securities and Exchange Commission for the fiscal year ended June 30, 2026, disclosing financial and operational details including a subsequent-event acquisition and share data as of August 6, 2026.

Richtech Robotics Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on August 19, 2026, covering the fiscal quarter ended June 30, 2026.

A Form 4 filed on August 19, 2026 reports that Michael W. Collins, Chief Executive Officer of Bank of N.T. Butterfield & Son Ltd (NYSE:NTB), sold a total of 207,037 ordinary shares across three consecutive trading days ending August 19, 2026, reducing his direct …